WAKEFIELD, MA, May 6 /CNW/ - NUCRYST Pharmaceuticals, a developer and
manufacturer of medical products that fight infection and inflammation, today
announced its financial results for the first quarter ended March 31, 2008.
Total revenues were $5.2 million for the first quarter of 2008, as compared
with $5.2 million in the first quarter of 2007. Total revenues in the first
quarter 2008 include wound care product revenues of $6.3 million, a 21%
increase from $5.2 million in the first quarter of 2007, which was offset by
the recognition during the quarter of $1.1 million of a $4.5 million
manufacturing cost rebate paid annually to Smith & Nephew under our supply
agreement.
